Esben Østrup

Esben Østrup

Auto-generated profile, based on publicly available information

Esben Østrup

Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in Epigenetics
Verified
Journal Article
Closed access
RDRahul S. Deshmukh
Rahul S. Deshmukh
OØOlga Østrup
Olga Østrup
EØEsben Østrup
Esben Østrup
MVMorten Vejlsted
Morten Vejlsted
HNHeiner Niemann
Heiner Niemann
PHPoul Hyttel
Poul Hyttel
DNA demethylation and remethylation are crucial for reprogramming of the differentiated parental/somatic genome in the recipient ooplasm upon somatic cell nuclear transfer. Here, we analyzed the DN...

1 August 2010 in Biology of Reproduction
Verified
Journal Article
Open access
PDF file
EØEsben Østrup
Esben Østrup
SBStefan Bauersachs
Stefan Bauersachs
HBHelmut Blum
Helmut Blum
EWEckhard Wolf
Eckhard Wolf
PHPoul Hyttel
Poul Hyttel
In an attempt to unveil molecular processes controlling the porcine placentation, we have investigated the pregnancy-induced gene expression in the e

1 April 2014 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
HPHelen Pullisaar
Helen Pullisaar
JRJanne E. Reseland
Janne E. Reseland
Håvard Jostein HaugenHåvard Jostein Haugen
Håvard Jostein Haugen
JBJan E. Brinchmann
Jan E. Brinchmann
EØEsben Østrup
Esben Østrup
Bone tissue engineering requires an osteoconductive scaffold, multipotent cells with regenerative capacity and bioactive molecules. In this study we investigated the osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells (hAD-MSCs) on titanium dioxide (TiO2) scaffold coated with alginate hydrogel containing various concentrations of simvastatin (SIM). The mRNA expression of osteoblast-related genes such as collagen type I alpha 1 (COL1A1), alkaline phosphatase (ALPL), osteopontin (SPP1), osteocalcin (BGLAP) and vascular endothelial growth factor A (VEGFA) was enhanced in hAD-MSCs cultured on scaffolds with SIM in comparison to scaffolds without SIM. Furthermore, the secretion of osteoprotegerin (OPG), vascular endothelial growth factor A (VEGFA), osteopontin (OPN) and osteocalcin (OC) to the cell culture medium was higher from hAD-MSCs cultured on scaffolds with SIM compared to scaffolds without SIM. The TiO2 scaffold coated with alginate hydrogel containing SIM promote osteogenic differentiation of hAD-MSCs in vitro, and demonstrate feasibility as scaffold for hAD-MSC based bone tissue engineering.

1 April 2014 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
BBB. Bjerregaard
B. Bjerregaard
JLJ. G. Lemmen
J. G. Lemmen
MPM. R. Petersen
M. R. Petersen
EØE. Østrup
E. Østrup
LIL. H. Iversen
L. H. Iversen
SZS. Ziebe
S. Ziebe

1 January 2013 in Journal of Tissue Engineering
Verified
Journal Article
Open access
HPHelen Pullisaar
Helen Pullisaar
HTHanna Tiainen
Hanna Tiainen
MLMaria A Landin
Maria A Landin
SLStåle P Lyngstadaas
Ståle P Lyngstadaas
Håvard Jostein HaugenHåvard Jostein Haugen
Håvard Jostein Haugen
EØEsben Østrup
Esben Østrup
The aim of this study was to develop a three-dimensional porous bone graft material as vehicle for simvastatin delivery and to investigate its effect on primary human osteoblasts from three donors. Highly porous titanium dioxide (TiO2) scaffolds were submerged into simvastatin containing alginate solution. Microstructure of scaffolds, visualized by scanning electron microscopy and micro-computed tomography, revealed an evenly distributed alginate layer covering the surface of TiO2 scaffold struts. Progressive and sustained simvastatin release was observed for up to 19 days. No cytotoxic effects on osteoblasts were observed by scaffolds with simvastatin when compared to scaffolds without simvastatin. Expression of osteoblast markers (collagen type I alpha 1, alkaline phosphatase, bone morphogenetic protein 2, osteoprotegerin, vascular endothelial growth factor A and osteocalcin) was quantified using real-time reverse transcriptase–polymerase chain reaction. Secretion of osteoprotegerin, vascular endothelial growth factor A and osteocalcin was analysed by multiplex immunoassay (Luminex). The relative expression and secretion of osteocalcin was significantly increased by cells cultured on scaffolds with 10 µM simvastatin when compared to scaffolds without simvastatin after 21 days. In addition, secretion of vascular endothelial growth factor A was significantly enhanced from cells cultured on scaffolds with both 10 nM and 10 µM simvastatin when compared to scaffolds without simvastatin at day 21. In conclusion, the results indicate that simvastatin-coated TiO2 scaffolds can support a sustained release of simvastatin and induce osteoblast differentiation. The combination of the physical properties of TiO2 scaffolds with the osteogenic effect of simvastatin may represent a new strategy for bone regeneration in defects where immediate load is wanted or unavailable.

9 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RJRune B. Jakobsen
Rune B. Jakobsen
EØEsben Østrup
Esben Østrup
XZXiaolan Zhang
Xiaolan Zhang
TMTarjei S. Mikkelsen
Tarjei S. Mikkelsen
JBJan E. Brinchmann
Jan E. Brinchmann
The in vitro process of chondrogenic differentiation of mesenchymal stem cells for tissue engineering has been shown to require three-dimensional culture along with the addition of differentiation factors to the culture medium. In general, this leads to a phenotype lacking some of the cardinal features of native articular chondrocytes and their extracellular matrix. The factors used vary, but regularly include members of the transforming growth factor β superfamily and dexamethasone, sometimes in conjunction with fibroblast growth factor 2 and insulin-like growth factor 1, however the use of soluble factors to induce chondrogenesis has largely been studied on a single factor basis. In the present study we combined a factorial quality-by-design experiment with high-throughput mRNA profiling of a customized chondrogenesis related gene set as a tool to study in vitro chondrogenesis of human bone marrow derived mesenchymal stem cells in alginate. 48 different conditions of transforming growth factor β 1, 2 and 3, bone morphogenetic protein 2, 4 and 6, dexamethasone, insulin-like growth factor 1, fibroblast growth factor 2 and cell seeding density were included in the experiment. The analysis revealed that the best of the tested differentiation cocktails included transforming growth factor β 1 and dexamethasone. Dexamethasone acted in synergy with transforming growth factor β 1 by increasing many chondrogenic markers while directly downregulating expression of the pro-osteogenic gene osteocalcin. However, all factors beneficial to the expression of desirable hyaline cartilage markers also induced undesirable molecules, indicating that perfect chondrogenic differentiation is not achievable with the current differentiation protocols.